161 related articles for article (PubMed ID: 36319622)
1. Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p.
Ding M; Zhao X; Chen X; Diao W; Kan Y; Cao W; Chen W; Jiang B; Qin H; Gao J; Zhuang J; Zhang Q; Guo H
Cell Death Discov; 2022 Nov; 8(1):439. PubMed ID: 36319622
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181d-5p-Containing Exosomes Derived from CAFs Promote EMT by Regulating CDX2/HOXA5 in Breast Cancer.
Wang H; Wei H; Wang J; Li L; Chen A; Li Z
Mol Ther Nucleic Acids; 2020 Mar; 19():654-667. PubMed ID: 31955007
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
5. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
6. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance.
Zhuang J; Shen L; Li M; Sun J; Hao J; Li J; Zhu Z; Ge S; Zhang D; Guo H; Huang R; Yan J
Cancer Res; 2023 May; 83(10):1611-1627. PubMed ID: 36939397
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
[TBL] [Abstract][Full Text] [Related]
9. Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.
Fan JT; Zhou ZY; Luo YL; Luo Q; Chen SB; Zhao JC; Chen QR
Neoplasia; 2021 Jul; 23(7):692-703. PubMed ID: 34153644
[TBL] [Abstract][Full Text] [Related]
10. Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells.
Wang M; Zhuoma C; Liu X; Huang Q; Cai G; Sang G; Zhou L; Du H; Wu C
Head Neck; 2022 Nov; 44(11):2437-2451. PubMed ID: 35866307
[TBL] [Abstract][Full Text] [Related]
11. Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β.
Wang S; Du P; Cao Y; Ma J; Yang X; Yu Z; Yang Y
Cell Death Discov; 2022 Aug; 8(1):371. PubMed ID: 35999213
[TBL] [Abstract][Full Text] [Related]
12. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
14. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-β1 positive feedback loop.
Zhang Y; Wang S; Lai Q; Fang Y; Wu C; Liu Y; Li Q; Wang X; Gu C; Chen J; Cai J; Li A; Liu S
Cancer Lett; 2020 Oct; 491():22-35. PubMed ID: 32730779
[TBL] [Abstract][Full Text] [Related]
16. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
[TBL] [Abstract][Full Text] [Related]
17. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts-derived exosomes upregulate microRNA-135b-5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxin-interacting protein.
Yin H; Yu S; Xie Y; Dai X; Dong M; Sheng C; Hu J
Cell Signal; 2021 Aug; 84():110029. PubMed ID: 33932496
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
20. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression.
Wang X; Qin X; Yan M; Shi J; Xu Q; Li Z; Yang W; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Apr; 38(1):151. PubMed ID: 30961650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
